Offer Quercetin, Troxerutin, Rutin

タイトルまたは説明

Details of Specification Name: Troxerutin Assay :*5.0% - **2.0% Export to Asia, USA and Europe CAS NO.: ********4 Molecular Formula: C*3H*2O*9 Molecular Weight: **2.*8 Assay :*5.0% - **2.0% Export to Asia, USA and Europe CAS NO.: ********4 Molecular Formula: C*3H*2O*9 Molecular Weight: **2.*8 Standard: EP 5.3/EP6/DAB***9 Chemical name : *-[3, *-Bis(*-hydroxyethoxy)phenyl]**-hydroxy**-(*-hydroxy-ethoxy)**-(*-O-a-L-rhamnopyranosyl-b-D-glucopyranosyloxy)*4H-chromen**-on Other names: 7, 3', 4'-Tris[O-(*-hydroxyethyl)] rutin; trioxyethylrutin; tri(hydroxyethyl) rutoside Physical form: Yellowish green powder Melting point:**8~**6°C M. F. & M. W. : C*3H*2O*9 Assay:*5.0% - **2.0% Particle size: **0% pass through *0 mesh Main peak: ≥*0.0% One peak:≤*0.*0% Single peak: ≤5.0% Ethylene oxide:≤1ppm Heavy metals: ≤*0.0ppm Loss on drying:≤5.0% Storage: avoid light, closeness, keep at the cool, dry place Valid: *4monthes Pharmacology: This product can inhibit platelet aggregation, prevent thrombosis, can cure the vascular injury induced by 5 serotonin or bradykinin, increase the capillary resistance, reduce the capillary permeability, prevent edema caused by the increasement of vascular permeability. It has the significant protective effect to acute ischemic brain injury. Applying As the treatment of cerebral thrombosis or the sequela due from the cerebral embolism, such as the hemiplegia, aphasia and myocardial infarction syndrome, arteriosclerosis, central retinitis, phlebitis of thrombosis, varicose veins, edema caused by the vascular permeability rising.